title: Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience.
abstract: BACKGROUND
  The effectiveness of the wearable cardioverter defibrillator (WCD) therapy in early post-myocardial infarction (MI) patients remains uncertain.
  
  
  METHODS
  We analyzed the characteristics and outcomes of patients who received a WCD in the early post-MI phase.
  
  
  RESULTS
  Twenty-four patients were followed-up for 8 months (range, 4-16 months). Two patients (8.3%) received appropriate shocks. Left ventricular ejection fraction improved after the WCD therapy (P<0.01). Fourteen patients (58%) received an implantable cardioverter defibrillator at the end of the follow-up period.
  
  
  CONCLUSIONS
  Early post-MI patients at high risk of sudden cardiac death may benefit from WCD therapy.
authors.affiliation: Department of Medicine-Cardiology, University of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, Germany.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Kondo
authors.affiliation: Department of Medicine-Cardiology, University of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Linhart
authors.affiliation: Department of Medicine-Cardiology, University of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, Germany.
authors.forename: René P
authors.initials: RP
authors.lastname: Andrié
authors.affiliation: Department of Medicine-Cardiology, University of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, Germany.
authors.forename: Joerg O
authors.initials: JO
authors.lastname: Schwab
keywords: Acute myocardial infarction; Implantable cardioverter defibrillator; Sudden cardiac death; Wearable cardioverter defibrillator